The global Intrauterine Contraceptive Devices (IUD) Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Hormonal Intrauterine Device, Copper Intrauterine Device), By End-User (Hospitals, Gynecology Clinics, Community Health Care Centers).
The Intrauterine Contraceptive Devices (IUD) Market comprises contraceptive devices inserted into the uterus to prevent pregnancy. This market includes hormonal IUDs and copper IUDs, offering long-term contraception with high efficacy and reversible options. Intrauterine devices are among the most effective forms of birth control, providing convenience, cost-effectiveness, and minimal user intervention. Innovations in intrauterine contraceptive devices focus on device design, hormonal delivery systems, biocompatibility, and non-hormonal alternatives, catering to diverse patient preferences and expanding options in family planning and reproductive health.
The global Intrauterine Contraceptive Devices (IUD) Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Intrauterine Contraceptive Devices (IUD) Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Intrauterine Contraceptive Devices (IUD) Industry include- AbbVie Inc, Bayer AG, CooperSurgical Inc, DKT International, EUROGINE, S.L, Melbea AG, Mona Lisa NV, Mylan NV, Ocon Medical Ltd, Pregna International Ltd, Prosan International BV, SMB Corp of India.
A significant trend in the market for intrauterine contraceptive devices (IUDs) is the increasing preference for long-acting reversible contraception (LARC) methods among women worldwide. IUDs offer highly effective contraception for extended durations, ranging from 3 to 10 years depending on the type of device, with minimal user intervention. This trend is driven by factors such as high contraceptive efficacy, convenience, and cost-effectiveness compared to other short-term contraceptive methods, leading to growing acceptance and adoption of IUDs as a preferred choice for birth control among women of reproductive age.
The primary driver of the intrauterine contraceptive devices market is the growing awareness of family planning, reproductive health, and women's rights globally. Increased access to education, healthcare services, and information about contraceptive options has empowered women to make informed decisions about their reproductive choices and contraceptive needs. As a result, there is a rising demand for safe, reliable, and reversible contraceptive methods like IUDs that offer long-term protection against unintended pregnancies while preserving fertility and reproductive autonomy, driving market growth and adoption of intrauterine contraceptive devices.
An opportunity in the intrauterine contraceptive devices market lies in the expansion into emerging markets and underserved populations with unmet contraceptive needs. Despite the proven efficacy and safety of IUDs, access barriers such as cost, availability, and cultural factors continue to limit adoption in many regions, particularly in low- and middle-income countries. Manufacturers can seize this opportunity by developing innovative, low-cost IUDs, and implementing targeted outreach and education programs to increase awareness and access to IUDs among marginalized communities, adolescents, and women with limited healthcare resources, ultimately promoting reproductive health equity and empowering women worldwide.
Among the different types of intrauterine contraceptive devices (IUDs), the Hormonal Intrauterine Device segment is experiencing the fastest growth. Hormonal IUDs release a small amount of progestin hormone into the uterus, which thickens the cervical mucus, inhibits sperm movement, and thins the uterine lining, thereby preventing fertilization and implantation of the egg. This type of IUD offers several advantages, including long-term effectiveness (up to 3-7 years depending on the brand), convenience, and minimal side effects. Additionally, hormonal IUDs are associated with reduced menstrual bleeding and cramping for many women, making them a preferred choice among healthcare providers and patients alike. The increasing awareness about the benefits of hormonal IUDs, coupled with initiatives to improve access to contraception in various healthcare settings such as hospitals, gynecology clinics, and community health care centers, has contributed to the rapid growth of this segment. As more women seek reliable and reversible contraceptive options, the demand for hormonal IUDs is expected to continue its upward trend, addressing the unmet need for effective family planning methods.
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
AbbVie Inc
Bayer AG
CooperSurgical Inc
DKT International
EUROGINE, S.L
Melbea AG
Mona Lisa NV
Mylan NV
Ocon Medical Ltd
Pregna International Ltd
Prosan International BV
SMB Corp of India
* List not Exhaustive
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Intrauterine Contraceptive Devices (IUD) Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Intrauterine Contraceptive Devices (IUD) Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Intrauterine Contraceptive Devices (IUD) Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Intrauterine Contraceptive Devices (IUD) Market Size Outlook, $ Million, 2021 to 2030
3.2 Intrauterine Contraceptive Devices (IUD) Market Outlook by Type, $ Million, 2021 to 2030
3.3 Intrauterine Contraceptive Devices (IUD) Market Outlook by Product, $ Million, 2021 to 2030
3.4 Intrauterine Contraceptive Devices (IUD) Market Outlook by Application, $ Million, 2021 to 2030
3.5 Intrauterine Contraceptive Devices (IUD) Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Intrauterine Contraceptive Devices (IUD) Industry
4.2 Key Market Trends in Intrauterine Contraceptive Devices (IUD) Industry
4.3 Potential Opportunities in Intrauterine Contraceptive Devices (IUD) Industry
4.4 Key Challenges in Intrauterine Contraceptive Devices (IUD) Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Intrauterine Contraceptive Devices (IUD) Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Intrauterine Contraceptive Devices (IUD) Market Outlook by Segments
7.1 Intrauterine Contraceptive Devices (IUD) Market Outlook by Segments, $ Million, 2021- 2030
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
8 North America Intrauterine Contraceptive Devices (IUD) Market Analysis and Outlook To 2030
8.1 Introduction to North America Intrauterine Contraceptive Devices (IUD) Markets in 2024
8.2 North America Intrauterine Contraceptive Devices (IUD) Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Intrauterine Contraceptive Devices (IUD) Market size Outlook by Segments, 2021-2030
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
9 Europe Intrauterine Contraceptive Devices (IUD) Market Analysis and Outlook To 2030
9.1 Introduction to Europe Intrauterine Contraceptive Devices (IUD) Markets in 2024
9.2 Europe Intrauterine Contraceptive Devices (IUD) Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Intrauterine Contraceptive Devices (IUD) Market Size Outlook by Segments, 2021-2030
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
10 Asia Pacific Intrauterine Contraceptive Devices (IUD) Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Intrauterine Contraceptive Devices (IUD) Markets in 2024
10.2 Asia Pacific Intrauterine Contraceptive Devices (IUD) Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Intrauterine Contraceptive Devices (IUD) Market size Outlook by Segments, 2021-2030
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
11 South America Intrauterine Contraceptive Devices (IUD) Market Analysis and Outlook To 2030
11.1 Introduction to South America Intrauterine Contraceptive Devices (IUD) Markets in 2024
11.2 South America Intrauterine Contraceptive Devices (IUD) Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Intrauterine Contraceptive Devices (IUD) Market size Outlook by Segments, 2021-2030
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
12 Middle East and Africa Intrauterine Contraceptive Devices (IUD) Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Intrauterine Contraceptive Devices (IUD) Markets in 2024
12.2 Middle East and Africa Intrauterine Contraceptive Devices (IUD) Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Intrauterine Contraceptive Devices (IUD) Market size Outlook by Segments, 2021-2030
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AbbVie Inc
Bayer AG
CooperSurgical Inc
DKT International
EUROGINE, S.L
Melbea AG
Mona Lisa NV
Mylan NV
Ocon Medical Ltd
Pregna International Ltd
Prosan International BV
SMB Corp of India
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Type
Hormonal Intrauterine Device
Copper Intrauterine Device
By End-User
Hospitals
Gynecology Clinics
Community Health Care Centers
The global Intrauterine Contraceptive Devices (IUD) Market is one of the lucrative growth markets, poised to register a 4.7% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
AbbVie Inc, Bayer AG, CooperSurgical Inc, DKT International, EUROGINE, S.L, Melbea AG, Mona Lisa NV, Mylan NV, Ocon Medical Ltd, Pregna International Ltd, Prosan International BV, SMB Corp of India
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume